-
Vitamin A is critical for the growth, development, visual function, and immune response of children, as along with other physiological processes (1). It is a leading cause of preventable childhood blindness and significantly contributes to both child morbidity and mortality (2). A World Health Organization (WHO) report from 2009 revealed that vitamin A deficiency (VAD) affects more than 190 million preschool-aged children globally, with a disproportionately higher prevalence in developing countries (3-4). Previous research has predominantly been focused on VAD in children under five and pregnant women (4-5), with limited data available for school-aged children. Nutrition Improvement Programme for Rural Compulsory Education Students (NIPRCES) is a government-funded plan aiming to improve malnutrition among children and adolescents in primary and secondary schools in Chinese rural areas (6-7). This paper presents findings on the prevalence of VAD and sub-clinical VAD (SVAD) among school-aged children in rural areas served by NIPRCES from 2012 to 2021. The results indicate a slight improvement, yet the issue remains significant and warrants continued attention.
From 2012 to 2017, annual surveys were carried out in 50 pilot counties across 22 provincial-level administrative divisions (PLADs) in rural China. This scope was expanded in 2021 to include 160 counties in all 31 PLADs. The surveys employed a stratified cluster sampling strategy, targeting approximately 360 students aged 6 to 17 years old within each county for the initial period. For the 2021 analysis, this study included data from 55 national pilot counties located in central and western China out of the expanded sample of 160 counties (6).
Morning fasting venous blood samples were collected from all participants to measure vitamin A levels. Serum was promptly separated, stored, and transported in darkness. Serum retinol concentrations were quantified utilizing High Performance Liquid Chromatography-Mass Spectrometry (HPLC-MS). VAD and SVAD were identified according to the standards set out in the Chinese Method for Vitamin A Deficiency Screening (WS/T 553-2017); concentrations below 0.70 µmol/L indicated VAD, while concentrations ranging from 0.70 µmol/L to 1.05 µmol/L indicated SVAD (8). Statistical analysis was performed with SAS software (version 9.4, SAS Institute Inc., Cary, NC, USA). Serum retinol concentrations were reported as medians with 25th and 75th percentiles. The Wilcoxon test and the Kruskal-Wallis rank-sum test were applied to assess differences between groups.
The total number of subjects from 2012 to 2021 was 7,531, 8,586, 10,468, 12,143, 12,955, 6,224, and 18,023, respectively. Table 1 presents the serum retinol levels across various age categories, sexes, and geographical locations. There was a notable increase in the median serum retinol concentration from 1.07 µmol/L in 2012 to 1.22 µmol/L in 2021. An age-associated rise in serum retinol was observed consistently over the study period (P<0.05). Females exhibited higher serum retinol levels than males from 2014 through 2021 (P<0.05), although the differences were not significant in 2012 and 2013. Geographically, serum retinol concentrations were higher in the western regions compared to central regions in 2012, 2015, and 2016, and lower in the years 2013, 2014, and 2021 (P<0.05).
Variable 2012 2013 2014 2015 2016 2017 2021 N P50 P25–P75 N P50 P25–P75 N P50 P25–P75 N P50 P25–P75 N P50 P25–P75 N P50 P25–P75 N P50 P25–P75 Total 7,531 1.07 0.9–1.27 7,586 1.11 0.94–1.31 10,468 1.13 0.94–1.40 12,143 1.12 0.94–1.29 12,955 1.08 1.05–1.40 6,224 1.19 1.01–1.40 18,023 1.22 1.03–1.43 Gender* Male 2,501 1.09 0.92–1.29 2,422 1.09 0.92–1.29 5,371 1.12 0.94–1.40 6,233 1.12 0.94–1.29 6,562 1.05 1.05–1.40 3,210 1.15 0.98–1.36 9,058 1.21 1.01–1.41 Female 2,424 1.11 0.91–1.31 2,328 1.11 0.93–1.31 5,097 1.15 0.95–1.40 5,910 1.12 0.94–1.33 6,393 1.12 1.05–1.40 2,973 1.19 1.01–1.40 8,965 1.24 1.05–1.46 Age group (years)* 6–8 730 0.99 0.86–1.16 792 1.00 0.86–1.16 1,907 1.05 0.87–1.26 2,101 0.98 0.84–1.15 2,261 1.05 0.91–1.22 1,003 1.08 0.94–1.26 3,081 1.12 0.95–1.32 9–11 1,221 1.05 0.88–1.23 1,378 1.05 0.89–1.23 3,017 1.08 0.94–1.33 3,907 1.05 0.91–1.22 4,092 1.05 0.98–1.40 2,035 1.12 0.98–1.33 5,980 1.17 1.00–1.37 12–14 1,121 1.19 0.99–1.38 1,192 1.14 0.98–1.36 3,561 1.19 0.98–1.46 3,792 1.15 0.98–1.36 4,248 1.26 1.05–1.40 2,113 1.22 1.05–1.40 6,000 1.28 1.08–1.48 15–17 770 1.30 1.08–1.54 700 1.26 1.06–1.49 1,983 1.23 1.05–1.54 2,343 1.22 1.05–1.43 2,304 1.40 1.05–1.47 1,057 1.29 1.12–1.50 2,879 1.36 1.13–1.59 Region Central 2,990 1.06 0.9–1.25 2,910 1.13 0.96–1.33 3,999 1.19 0.99–1.47 5,492 1.08 0.94–1.29 5,373 1.05 1.05–1.40 1,384 1.19 0.98–1.36 4,642 1.22 1.05–1.43 Western 4,541 1.08 0.9–1.29 4,676 1.10 0.93–1.3 6,469 1.08 0.91–1.37 6,651 1.12 0.94–1.33 7,582 1.15 1.05–1.40 4,840 1.19 1.01–1.40 13,381 1.22 1.02–1.43 * Variables of age group and genders have some missing data in 2012, 2013, 2017 and 2021. Table 1. Serum retinol concentrations of vitamin A (µmol/L) based on age, gender and region from 2012–2021.
The prevalence rates of SVAD and VAD fluctuated over the seven-year period, as illustrated in Figure 1. The highest occurrence of SVAD and VAD was recorded in 2013, at 38.1% and 4.1%, respectively, while the lowest rates were observed in 2016, at 20.0% for SVAD and 1.5% for VAD.
Figure 1.Prevalence of sub-clinical VAD and VAD in children aged 6 to 17 years from 2012 to 2021.
Abbreviation: VAD=vitamin A deficiency; SVAD=sub-clinical vitamin A deficiency.In Figure 2, prevalence of SVAD and VAD among different age groups from 2012 to 2021 is depicted. For the age group of 6–8 years, VAD prevalence decreased from 8.1% to 4.6%, and for the 15–17 years age group, it decreased from 2.6% to 1.7%.
Figure 2.Prevalence of SVAD and VAD in different age groups, sexes, and areas from 2012 to 2021. (A) 6–8 years age group; (B) 9–11 years age group; (C) 12–14 years age group; (D) 15–17 years age group; (E) Male; (F) Female; (G) Central area; (H) Western area.
Abbreviation: VAD=vitamin A deficiency; SVAD=sub-clinical vitamin A deficiency.The VAD in males from 2012 to 2021 was recorded as follows: 5.8%, 4.2%, 4.4%, 3.5%, 1.8%, 1.9%, and 3.5%, respectively. Correspondingly, the rates for females were 6.1%, 3.9%, 4.0%, 3.0%, 1.2%, 1.4%, and 3.4%. During the period from 2013 to 2021, the prevalence of VAD was consistently higher in males compared to females, evidencing a decline from 5.8% to 3.5% in males, and a decrease from 6.1% to 3.4% in females (Figure 2).
The VAD of western areas from 2012 to 2021 was 6.9%, 3.8%, 5.5%, 3.3%, 1.5%, 1.5% and 4.3%, and that of central areas was 4.8%, 3.2%, 2.0%, 3.1%, 1.6%, 2.0% and 1.0%, respectively. Notably, the VAD prevalence was higher in western regions compared to central regions in 2013, 2014, and 2021, but the differences were not statistically significant in 2012, 2015, 2016, and 2017 (Figure 2).
HTML
Citation: |